Alembic receives tentative nod for 2 genericsAlembic has received tentative approval from the Food and Drug Administration for dronedarone tablets and vortioxetine tablets. Walgreens, VillageMD bring clinics to Tucson, Ariz.The eight clinic openings represent an expansion into Arizona’s second major market and add to the growing number of locations in the state, the companies said. Unilever’s rejected offer for GSK consumer healthcare reportedly raises questions The bid for GSK’s assets, including Sensodyne toothpaste and Advil painkillers, comes as Unilever is dealing with steep inflation and sluggish growth in emerging markets. Amneal to acquire Saol Therapeutics’ Baclofen franchise The acquisition expands Amneal’s neurology presence into spasticity. U.S. Court of Appeals for the Federal Circuit upholds validity of Novartis’ Gilenya dosage regimen patent Novartis said it expects no generic versions of Gilenya in the U.S. market for at least the next two years. Walgreens Boots Alliance reportedly begins strategic review of U.K.-based Boots Walgreens Boots Alliance has begun a strategic review of its Boots business as it considers how to proceed with the U.K. chain, according to a report. SpartanNash promotes from within for chief marketing officer role Amy McClellan has been promoted to senior vice president and chief marketing officer, effective immediately. Billie makes brick-and-mortar debut at Walmart Billie is launching its shave products at more than 4,000 Walmart stores in February and online at Walmart.com. Omnicell acquires MarkeTouch Media The acquisition is expected to expand the footprint of Omnicell’s EnlivenHealth division across the retail pharmacy sector. Walgreens Boots Alliance raises guidance amid strong Q1 results Walgreens Boots Alliance beat analysts’ expectations for fiscal first-quarter earnings as customers came to stores for COVID-19 vaccines and tests. First Previous 73 74 75 76 77 Next Last
